Trial Profile
A randomised, open label, crossover study to evaluate the relative bioavailability of a three-dimensional printed fast melt containing levetiracetam in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Seizures
- Focus Adverse reactions; Pharmacokinetics
- 05 Apr 2016 New trial record
- 30 Mar 2016 Results published in the Drugs in R and D